Cinclus Pharma Holding AB (publ) (STO:CINPHA)
Sweden · Delayed Price · Currency is SEK 18.78
-0.68 (-3.49%)
At close: Jan 20, 2026
Cinclus Pharma Holding AB Market Cap
Cinclus Pharma Holding AB has a market cap or net worth of 873.98 million as of January 21, 2026. Its market cap has decreased by -12.16% in one year.
Market Cap
873.98M
Enterprise Value
342.41M
Revenue
48.42M
Ranking
n/a
PE Ratio
n/a
Stock Price
18.78
Market Cap Chart
Since June 20, 2024, Cinclus Pharma Holding AB's market cap has decreased from 1.52B to 873.98M, a decrease of -42.40%. That is a compound annual growth rate of -29.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 873.98M | -2.49% |
| Dec 30, 2025 | 896.32M | -9.92% |
| Dec 30, 2024 | 994.98M | -34.43% |
| Jun 20, 2024 | 1.52B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioGaia AB | 10.94B |
| Cereno Scientific AB | 1.99B |
| EQL Pharma AB | 1.65B |
| Orexo AB | 1.05B |
| Dicot Pharma AB | 592.76M |
| Nanexa AB | 533.15M |
| Enzymatica AB | 476.97M |
| Moberg Pharma AB | 446.51M |